Evidence map›Paper›PMID 30012524›Full record

ReviewInternational journal of radiation oncology, biology, physics2018

Emerging Magnetic Resonance Imaging Technologies for Radiation Therapy Planning and Response Assessment.

Kyle M Jones, Keith A Michel, James A Bankson, Clifton D Fuller, Ann H Klopp, Aradhana M Venkatesan

Abstract readReviewVideo-Audio Media
In one paragraph

Review in International journal of radiation oncology, biology, physics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. The role of radiomics in prostate cancer radiotherapy.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2020
    Review
  20. First prospective clinical evaluation of feasibility and patient acceptance of magnetic resonance-guided radiotherapy in Germany.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2020
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kyle M JonesSection of Abdominal Imaging, Department of Diagnostic Radiology, Division of Diagnostic Imaging, MD Anderson Cancer Center, Houston, Texas; Department of Imaging Physics, Division of Diagnostic Imaging, MD Anderson Cancer Center, Houston, Texas.
Keith A MichelDepartment of Imaging Physics, Division of Diagnostic Imaging, MD Anderson Cancer Center, Houston, Texas.
James A BanksonDepartment of Imaging Physics, Division of Diagnostic Imaging, MD Anderson Cancer Center, Houston, Texas.
Clifton D FullerDepartment of Radiation Oncology, Division of Radiation Oncology, MD Anderson Cancer Center, Houston, Texas.
Ann H KloppDepartment of Radiation Oncology, Division of Radiation Oncology, MD Anderson Cancer Center, Houston, Texas.
Aradhana M VenkatesanSection of Abdominal Imaging, Department of Diagnostic Radiology, Division of Diagnostic Imaging, MD Anderson Cancer Center, Houston, Texas. Electronic address: avenkatesan@mdanderson.org.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Development of functional magnetic resonance imaging-guided adaptive radiotherapy for head and neck cancer patients using novel MR-Linac deviceR01DE028290 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI CHRISTODOULEAS, JOHN PAUL, FULLER, CLIFTON DAVID · 2019 to 2023
$4.3M
NCI NIH HHS P30 CA016672NIDCR NIH HHS R01 DE028290
6 · The paper itself

Abstract

Functional and molecular MRI techniques are capable of measuring biologic properties of tumor tissue. Knowledge of these biological properties may improve radiation treatment by more accurately identifying tumor volumes, characterizing radioresistant subvolumes of tumor before radiation therapy (RT), and identifying recurrent disease after RT. Intravoxel incoherent motion MRI, blood oxygenation level-dependent MRI, tissue oxygenation level-dependent MRI, hyperpolarized

Indexed as

Brain NeoplasmsChemoradiotherapyDisease ProgressionGlioblastomaHumansHypoxiaKineticsMagnetic Resonance ImagingMotionNeoplasm Recurrence, LocalOxygenRadiotherapyRadiotherapy Planning, Computer-AssistedOxygen

Identifiers

PMID30012524
PMCPMC9671538

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.